Martel v. SSA

2013 DNH 157
CourtDistrict Court, D. New Hampshire
DecidedNovember 18, 2013
Docket13-cv-48-PB
StatusPublished
Cited by4 cases

This text of 2013 DNH 157 (Martel v. SSA) is published on Counsel Stack Legal Research, covering District Court, D. New Hampshire primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Martel v. SSA, 2013 DNH 157 (D.N.H. 2013).

Opinion

Martel v . SSA 13-cv-48-PB 11/18/13 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW HAMPSHIRE

Daniel Martel

v. Civil N o . 13-cv-48-PB Opinion N o . 2013 DNH 157 U.S. Social Security Administration, Commissioner

MEMORANDUM AND ORDER

Daniel Martel seeks judicial review of a ruling by the

Commissioner denying his application for disability insurance

benefits (“DIB”) and supplemental security income (“SSI”).

Martel claims that findings of the Administrative Law Judge

(“ALJ”) regarding his residual functional capacity (“RFC”) and

his ability to perform past relevant work are not supported by

substantial evidence. For the reasons set forth below, I deny

Martel’s request and affirm the decision of the Commissioner.

I. BACKGROUND1

A. Procedural History

Martel applied for DIB and SSI on June 2 8 , 2008, alleging a

disability onset date of April 2 3 , 2006. After the Commissioner

denied his application, Martel requested a hearing before an

1 The background information is taken from the parties’ Joint Statement of Material Facts (Doc. N o . 1 1 ) . Citations to the Administrative Transcript are indicated by “Tr.” ALJ, which was held on February 1 8 , 2010. Martel was

represented by an attorney and testified at the hearing, but no

medical or vocational expert (“VE”) testified. On April 2 2 ,

2010, the ALJ issued a decision finding that Martel was not

disabled under the Social Security Act. On July 2 6 , 2010, the

Social Security Decision Review Board, after reviewing Martel’s

claim, remanded the case to the ALJ to hold a second hearing and

further develop the record.

On June 1 6 , 2011, the ALJ held a second hearing. Martel,

again represented by an attorney, testified, as did a medical

expert and V E . On July 2 8 , 2011, the ALJ issued his decision,

again finding Martel not disabled. On December 3 , 2012, the

Appeals Council denied Martel’s request for review, making the

ALJ’s decision the Commissioner’s final decision and therefore

subject to judicial review.

B. Medical History

Martel was fifty-two years old on his alleged onset date.

From roughly 1977 to 1995, he worked as a machine operator.

After his employer closed its facility, Martel worked as a

general laborer through various temporary employment agencies

from 1995 until 2006. During this period, he worked as a

machine operator, fabrics layer, and mail sorter, among other

positions. T r . at 280. Martel claims that he became disabled 2 in 2006 due to both physical and mental impairments.

1. Alleged Physical Impairments

In August 2002, Martel underwent a liver biopsy for

hepatitis C , resulting in a final diagnosis of “chronic

hepatitis C with grade 3 activity and stage 3 fibrosis.”2 In a

consultative examination with D r . Darlene Gustavson, Psy.D.,

Martel reported that hepatitis had never interfered with his job

functioning. T r . at 342. D r . Gustavson included a diagnosis of

hepatitis B and C in her final report. D r . John Newcomb also

noted Martel’s history of hepatitis. In March 2011, nurse

practitioner Jill S t . George ordered further laboratory testing

for Martel’s hepatitis. At his February 1 8 , 2010 hearing,

Martel was questioned by his attorney about his hepatitis. He

reported that he had the disease, but expressed uncertainty as

to what treatments he received. T r . at 3 5 . During his June 1 6 ,

2011 hearing, Martel noted that he had once undergone treatment

for five months, but stopped when it made him sick. T r . at 6 1 .

2. Alleged Mental Impairments

a. Treatment Notes

From at least March 2006 through December 2009, Martel was

2 Chronic hepatitis C is a viral liver disease that often progresses to cirrhosis. Stedman’s Medical Dictionary 875-76 (28th ed. 2006). Fibrosis is the “[f]ormation of fibrous tissue as a reparative or reactive process.” Id. at 726. 3 treated by Leslie Clukay, a nurse practitioner at the Mental

Health Center of Greater Manchester. Clukay’s treatment notes

from this period consistently refer to Martel as “anxious” and

note that his speech was hesitant on several visits. At times,

Martel’s mood was described as “euthymic” or “not depressed.”3

Medication lists show that Martel frequently took Zoloft, though

in February 2009 he switched to Citalopram after complaining

about Zoloft’s ineffectiveness.4 In July 2009 Clukay

discontinued Citalopram and switched Martel back to Zoloft.

On a visit in September 2006, Martel denied having

depressive symptoms and reported feeling “really good,” but was

noted to be quite anxious at baseline. In January 2007, Martel

reported that he wanted to work but was limited by his inability

to drive. In September 2007, Martel expressed frustration with

his continuing job search. Otherwise, he reported feeling “ok”

3 Euthymia is a mental state involving “moderation of mood, not manic or depressed,” and can present as “joyfulness[ or] mental peace and tranquility.” Id. at 678. 4 Zoloft is prescribed for the treatment o f , among other conditions, social anxiety disorder, major depressive disorder, and panic disorder. Physicians’ Desk Reference 2588 (61st ed. 2007). Citalopram is used to treat depression, but can be used off-label to treat anxiety and panic disorders. See, e.g., I . Varia & F. Rauscher, Treatment of Generalized Anxiety Disorder with Citalopram, 17 Int’l Clinical Psychopharmacology, May 2002, at 103-07 (clinical study finding that Citalopram may be an effective treatment for generalized anxiety disorder).

4 and that his medication was “fine.” T r . at 322. Clukay

observed no evidence of depressive or panic symptoms, but noted

that Martel’s affect was flat. Id. Martel reported continuing

frustration with his job search and unemployment in January

2008, at which point he also reported panic upon leaving his

house. In May 2008, Martel reported continuing to avoid crowds

and social situations and requested a decrease in his medication

dosage to alleviate a side-effect of excessive sweating.

In February 2009, Martel reported being more anxious and

that his medication was not working. At this point, Clukay

characterized Martel’s mood as “anxious, not depressed.” T r . at

38. During a follow-up appointment in May, Martel said that the

medication made him less anxious and that his mood had

stabilized. Clukay found Martel’s attention span and

concentration to be normal, his memory intact, his mood

euthymic, and his affect very anxious. In July 2009, Martel

reported that he had ceased taking medication due to its

ineffectiveness and reported increased depressive and anxious

symptoms. Clukay observed that Martel’s memory was intact and

attention span and concentration were normal, though he was

anxious and preoccupied. She discontinued Citalopram and again

prescribed him Zoloft. In August 2009, Clukay noted that Martel

reported “increased depressive symptoms.” T r . at 383. 5 b. Consultative Examinations and Opinions

i . D r . Darlene Gustavson

On August 2 9 , 2008, D r . Gustavson conducted a consultative

psychological evaluation of Martel. Martel rode his bicycle to

the appointment, explaining that he had lost his driver’s

license in 2006 for a second DUI offense and did not wish to

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hafford v. SSA
2017 DNH 060 (D. New Hampshire, 2017)
Douglas v SSA
2016 DNH 176 (D. New Hampshire, 2016)
Allard v. SSA
2014 DNH 034 (D. New Hampshire, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
2013 DNH 157, Counsel Stack Legal Research, https://law.counselstack.com/opinion/martel-v-ssa-nhd-2013.